Plague: A decade since the 1994 outbreaks in India

Journal of Association of Physicians of India

Volumn 53, Issue MAY, 2005, Pages 457-464

  Clem, Angela ^a   Galwankar, S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIC; HEALTH SURVEY; HUMAN; INDIA; ISOLATION AND PURIFICATION; PATHOPHYSIOLOGY; PLAGUE; REVIEW; TIME; YERSINIA PESTIS;

DISEASE OUTBREAKS; HUMANS; INDIA; PLAGUE; POPULATION SURVEILLANCE; TIME FACTORS; YERSINIA PESTIS;

EID: 24644503586     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Persad A. History of bioterrorism. The Indian Practitioner 2001;54:857-63.
2. Clem A. The potential of plague as a biological weapon. The Indian Practitioner 2001;54:878-88.
3. Donnenberg MS. Pathogenic strategies of enteric bacteria. Nature 2000;406:768-74.
4. Clarke T. Smallpox selective potential. Nature 2003;426:618.
5. Mecsas J, Franklin G, Kuziel WA, Brubaker RR, Falkow S, et al. CCR5 mutation and plague protection. Nature 2004;427:606.
6. Elvin SJ, Williamson ED, Scott JC, Smith JN, Perez de Lema, G, et al. Brief communication arising Ambiguous role of CCR5 in Y. pestis infection. Nature 2004;427.
7. Cole ST, Buchrieser C. A plague o' both your hosts. Nature 2001;413:467-70.
8. Pujol C, Bliska JB. The ability to replication in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infection and Immunity 2003;71:5892-9.
9. Garcia E, Motin V, Brubaker R, Fitch P. Global expression studies of Yersinia pestis pathogenicity (UCRL-ID-150483) 2002; Lawrence Livermore National Laboratory.
10. Merrell DS, Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature 2004;430:250-6.
11. Centers for Disease Control and Prevention. Imported plague - New York City, 2002. MMWR 2003;52:725-8.
12. Anisimov AP, Lindler LE, Pier JB. Intraspecific Diversity of Yersinia pestis. Clinical Microbiology Reviews 2004;17:434-64. [abstract].
13. Zhou D, Tong Z, Song Y, Han Y, Pei D, et al. Genetics of Metabolic Variations between Yersinia pestis Biovars and the Proposal of a New Biovar, microtus. Journal of Bacteriology 2004;186:5147-52. [abstract]
14. Check, Erica. Plague professor gets two years in bioterror case. Nature 2004;428:242.
15. Manbir Online. History of plague. Available online www.manbir-online.com/ diseases/plagur-history.htm [2 August, 2004].
16. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. The Plague Virulence Protein YopM Targets the Innate Immune Response by Causing a Global Depletion of NK Cells. Infection & Immunity 2004;72:4589-602.
17. Darby C, Hsu JW, Ghori N, Falkow S. Plague bacteria biofilm blocks food intake. Nature 2002;417:243-4.
18. Brubaker RR. (200). Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen). Infection and Immunity 2003;71:3673-81.
19. Ber R, Mamroud E, Aftalion M, Tidhar A, Gur D, et al. Development of an improved selective agar medium for isolation of Yersinia pestis. Applied and Environmental Microbiology 2003;69:5787-92.
20. Bogdanovich T, Carniel E, Fukushima H, Skurnik M. Use of O-antigen gene cluster-specific PCRs for the identification and O-genotyping of Yersinia pseudotuberculosis and Yersinia pestis. Journal of Clinical Microbiology 2003;41:5103-12.
21. Loiez C, Herwegh S, Wallet F, Armand S, Guinet F, et al. Detection of Yersinia pestis in sputum by real-time PCR. Journal of Clinical Microbiology 2003;41:4873-5.
22. Gani R, Leach S. Epidemiologic determinants for modeling pneumonic plague outbreaks. Emerging Infectious Diseases 2004;10:608-14.
23. Rose LJ, Donlan R, Banerjee SN, Arduino MJ. Survival of Yersinia pestis on Environmental Surfaces. Applied and Environmental Microbiology 2003;69:2166-71.
24. Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, et al. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infection and Immunity 2003;71:374-83.
25. Hill J, Copse C, Leary S, Stagg AJ, Williamson ED, Titball RW. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis. Infection and Immunity 2003;71:2234-8.
26. ID Biomedical Announces New Data From Plague Vaccine. Infection Control Today. Available online http://www.infectioncontroltoday.com [Accessed on 19 July 2004].
27. Groseclose SL, Brathwaite WS, Hall PA, Adams DA, Connor FJ, et al. Summary of Notifiable Diseases - United States, 2002. MMWR 2004;51/(53),1-84.
28. World Health Organization Communicable Disease Surveillance & Response. Plague in Algeria - Update 2 2003; Available online http://www.who.int/csr/don/2003_07_10/en/print.html [Accessed on18 July 2004].
29. World Health Organization Communicable Disease Surveillance & Response. 2002 - Plague in Malawi 2002. Available online http://www.who.int/csr/ don/2002_06_05e/en/print.html [Accessed on 18 July 2004].
30. World Health Organization Communicable Disease Surveillance & Response. 2002 - Plague in India 2002. Available online http://www.who.int/csr/ don/2002_02_20/en/print.html [Accessed on 18 July 2004].
31. World Health Organization Communicable Disease Surveillance & Response (2001). 2001 - Plague in Zambia. Available online http://www.who.int/ csr/don/2001_03_26/en/print.html [Accessed on 18 July 2004].
32. Keeling MJ, Gilligan CA. (2000). Metapopulation dynamics of bubonic plague. Nature 2000;407:903-6.
33. Tysmans JB. Plague in India-l994 Conditions, Containment, Goals. Available online http://www.ucis.unc.edu/Resources/pubs/carolina/Plague.html [Accessed 2 August 2004].
34. National Institute of Communicable Diseases. Annual report 1997. Available online www.nicd.org/1997AnnRep04j.asp [Accessed on 2 August 2004].
35. The Fifth Decade- 50 years of WHO in South East Asia (Contud 9). Available online w3.whosea.org/aboutsearo/88-97-8.htm [Accessed on 2 August 2004].
36. Webster PJ, Palmer TN. The past and future of El Nino. Nature 1997;390:562-4.
37. Centers for Disease Control and Prevention. Lesson 5 medical management. Available online http://www.bt.cdc.gov/agent/plague/trainingmodule/5/ [Accessed 2 August 2004].
38. Prasad KH. (2001). The medical implications of biological and chemical terrorism. The Indian Practitioner 2001;54:916-33.
39. Fritz CL, Dennis DT, Tipple MA, Campbell GL, McCance CR, et al. Surveillance for Pneumonic Plague in the United States During an International Emergency: A Model for Control of Imported Emerging Diseases. Emerging Infectious Diseases 1996; 2(1). Available online www.cdc.gov/ncidod/EID/vol2no1/ downfrit.htm [Accessed on 2 August 2004].